James R. Kintzing

777 total citations
10 papers, 639 citations indexed

About

James R. Kintzing is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Immunology and Allergy. According to data from OpenAlex, James R. Kintzing has authored 10 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Immunology and Allergy. Recurrent topics in James R. Kintzing's work include Peptidase Inhibition and Analysis (5 papers), Cell Adhesion Molecules Research (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). James R. Kintzing is often cited by papers focused on Peptidase Inhibition and Analysis (5 papers), Cell Adhesion Molecules Research (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). James R. Kintzing collaborates with scholars based in United States and Russia. James R. Kintzing's co-authors include Jennifer R. Cochran, Ann Hanna, Craig L. Duvall, Mukesh Kumar Gupta, Christopher E. Nelson, Gerald A. Grant, Mark Smith, Sean Dangelmajer, Allen L. Ho and Nicolas Currier and has published in prestigious journals such as Angewandte Chemie International Edition, ACS Nano and Trends in Pharmacological Sciences.

In The Last Decade

James R. Kintzing

9 papers receiving 630 citations

Peers

James R. Kintzing
Bethany Powell Gray United States
Shunzi Li United States
Michael W. Handlogten United States
Sibu Balan United Kingdom
Rike Wallbrecher Netherlands
George K. Ehrlich United States
Bethany Powell Gray United States
James R. Kintzing
Citations per year, relative to James R. Kintzing James R. Kintzing (= 1×) peers Bethany Powell Gray

Countries citing papers authored by James R. Kintzing

Since Specialization
Citations

This map shows the geographic impact of James R. Kintzing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James R. Kintzing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James R. Kintzing more than expected).

Fields of papers citing papers by James R. Kintzing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James R. Kintzing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James R. Kintzing. The network helps show where James R. Kintzing may publish in the future.

Co-authorship network of co-authors of James R. Kintzing

This figure shows the co-authorship network connecting the top 25 collaborators of James R. Kintzing. A scholar is included among the top collaborators of James R. Kintzing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James R. Kintzing. James R. Kintzing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Cherf, Gerald Maxwell, et al.. (2024). An engineered ultrahigh affinity bi‐paratopic uPAR targeting agent confers enhanced tumor targeting. Biotechnology and Bioengineering. 121(10). 3169–3180.
2.
Shams, Hengameh, Frank V. Cochran, José Luís Izquierdo Alonso, et al.. (2019). Structural Basis of the Differential Binding of Engineered Knottins to Integrins αVβ3 and α5β1. Structure. 27(9). 1443–1451.e6. 12 indexed citations
3.
Currier, Nicolas, Shelley E. Ackerman, James R. Kintzing, et al.. (2016). Targeted Drug Delivery with an Integrin-Binding Knottin–Fc–MMAF Conjugate Produced by Cell-Free Protein Synthesis. Molecular Cancer Therapeutics. 15(6). 1291–1300. 30 indexed citations
4.
Kintzing, James R., et al.. (2016). Emerging Strategies for Developing Next-Generation Protein Therapeutics for Cancer Treatment. Trends in Pharmacological Sciences. 37(12). 993–1008. 154 indexed citations
5.
Kintzing, James R. & Jennifer R. Cochran. (2016). Engineered knottin peptides as diagnostics, therapeutics, and drug delivery vehicles. Current Opinion in Chemical Biology. 34. 143–150. 95 indexed citations
6.
Kintzing, James R., et al.. (2016). Integrin‐Targeting Knottin Peptide–Drug Conjugates Are Potent Inhibitors of Tumor Cell Proliferation. Angewandte Chemie. 128(34). 10048–10051. 6 indexed citations
7.
Connolly, Ian D., et al.. (2016). Sports-related brain injuries: connecting pathology to diagnosis. Neurosurgical FOCUS. 40(4). E14–E14. 24 indexed citations
8.
Kintzing, James R., et al.. (2016). Integrin‐Targeting Knottin Peptide–Drug Conjugates Are Potent Inhibitors of Tumor Cell Proliferation. Angewandte Chemie International Edition. 55(34). 9894–9897. 68 indexed citations
9.
Ackerman, Shelley E., Christy Wilson, Suzana Assad Kahn, et al.. (2014). A Bioengineered Peptide That Localizes To And Illuminates Medulloblastoma: A New Tool With Potential For Fluorescence-Guided Surgical Resection. Cureus. 6(9). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026